Keri L. Monda, Ph.D.
Affiliations: | 2006 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Nutrition, Public HealthGoogle:
"Keri Monda"Cross-listing: PHTree
Parents
Sign in to add mentor| Barry M. Popkin | grad student | 2006 | UNC Chapel Hill | |
| (China's nutrition transition: The effects of rapid social change on adult activity patterns and overweight.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Colantonio LD, Hubbard D, Monda KL, et al. (2020) Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease. Journal of the American College of Cardiology. 76: 251-264 |
| Rymer JA, Mues KE, Monda KL, et al. (2020) Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation. Journal of the American Heart Association. e014347 |
| Brown TM, Bittner V, Colantonio LD, et al. (2020) Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction. Journal of Clinical Lipidology |
| Reynolds K, Mues KE, Harrison TN, et al. (2019) Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system. Vascular Medicine (London, England). 1358863X19871100 |
| Chamberlain AM, Cohen SS, Killian JM, et al. (2019) Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease. The American Journal of Cardiology |
| Bittner V, Colantonio LD, Dai Y, et al. (2019) Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries. Jama Cardiology |
| Colantonio LD, Monda KL, Rosenson RS, et al. (2019) Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria. Cardiovascular Drugs and Therapy |
| Mefford MT, Rosenson RS, Deng L, et al. (2019) Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999-2014. Journal of the American Heart Association. 8: e010640 |
| Colantonio LD, Rosenson RS, Deng L, et al. (2019) Adherence to Statin Therapy Among US Adults Between 2007 and 2014. Journal of the American Heart Association. 8: e010376 |
| Levitan E, Poudel B, Zhao H, et al. (2019) P6206Death, debility, and destitution following recurrent myocardial infarction in older adults European Heart Journal. 40 |